Clinical studies suggest that short-term insulin treatment in new-onset type 2 diabetes (T2DM) can promote prolonged glycemic control. The purpose of this study was to establish an animal model to examine such a “legacy” effect of early insulin therapy (EIT) in long-term glycemic control in new-onset T2DM. The objective of the study was to investigate the role of diet following onset of diabetes in the favorable outcomes of EIT.As such, C57BL6/J male mice were fed a high-fat diet (HFD) for 21 weeks to induce diabetes and then received 4 weeks of daily insulin glargine or sham subcutaneous injections. Subsequently, mice were either kept on the HFD or switched to a low-fat diet (LFD) for 4 additional weeks.Mice fed a HFD gained significant fa...
Objective: This study aims to produce a mouse model of type 2 diabetes by using high fat diet. The C...
This study evaluated the relative contribution of insulin-dependent mechanisms vs. mechanisms indepe...
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various...
Clinical studies suggest that short-term insulin treatment in new-onset type 2 diabetes (T2DM) can p...
<div><p>Background</p><p>Clinical studies suggest that short-term insulin treatment in new-onset typ...
Background Clinical studies suggest that short-term insulin treatment in new-onset type 2 diabetes (...
This study characterizes the high-fat diet-fed mouse as a model for impaired glucose tolerance (IGT)...
The persistent rise in global incidence of type 2 diabetes (T2D) continues to have significant publi...
OBJECTIVES: Environmental factors such as a high-fat diet contribute to type 2 diabetes and obesity....
The persistent rise in global incidence of type 2 diabetes (T2D) continues to have significant publi...
Background: The C57BL/6 mouse fed a high fat diet is a common and valuable model in experimental stu...
Evidence has emerged supporting a link between high glycaemic index (GI) diets and type 2 diabetes (...
Evidence has emerged supporting a link between high glycaemic index (GI) diets and type 2 diabetes (...
The persistent rise in global incidence of type 2 diabetes (T2D) continues to have significant publi...
The persistent rise in global incidence of type 2 diabetes (T2D) continues to have significant publi...
Objective: This study aims to produce a mouse model of type 2 diabetes by using high fat diet. The C...
This study evaluated the relative contribution of insulin-dependent mechanisms vs. mechanisms indepe...
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various...
Clinical studies suggest that short-term insulin treatment in new-onset type 2 diabetes (T2DM) can p...
<div><p>Background</p><p>Clinical studies suggest that short-term insulin treatment in new-onset typ...
Background Clinical studies suggest that short-term insulin treatment in new-onset type 2 diabetes (...
This study characterizes the high-fat diet-fed mouse as a model for impaired glucose tolerance (IGT)...
The persistent rise in global incidence of type 2 diabetes (T2D) continues to have significant publi...
OBJECTIVES: Environmental factors such as a high-fat diet contribute to type 2 diabetes and obesity....
The persistent rise in global incidence of type 2 diabetes (T2D) continues to have significant publi...
Background: The C57BL/6 mouse fed a high fat diet is a common and valuable model in experimental stu...
Evidence has emerged supporting a link between high glycaemic index (GI) diets and type 2 diabetes (...
Evidence has emerged supporting a link between high glycaemic index (GI) diets and type 2 diabetes (...
The persistent rise in global incidence of type 2 diabetes (T2D) continues to have significant publi...
The persistent rise in global incidence of type 2 diabetes (T2D) continues to have significant publi...
Objective: This study aims to produce a mouse model of type 2 diabetes by using high fat diet. The C...
This study evaluated the relative contribution of insulin-dependent mechanisms vs. mechanisms indepe...
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various...